AAAAAA

   
Results: 1-13 |
Results: 13
THE 20210A ALLELE OF THE PROTHROMBIN GENE IS NOT A RISK FACTOR FOR RETINAL VEIN OCCLUSION
Authors: DELAHOUSSE B ARSENE S PIQUEMAL R IOCHMANN S LELEZ ML POUPLARD C GRUEL Y
Citation: B. Delahousse et al., THE 20210A ALLELE OF THE PROTHROMBIN GENE IS NOT A RISK FACTOR FOR RETINAL VEIN OCCLUSION, Blood coagulation & fibrinolysis, 9(5), 1998, pp. 447-448
CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO
Authors: ROBERT A LEQUERREC A DELAHOUSSE B CARON C HOUBOUYAN L BOUTIERE B HORELLOU MH REBER G SIE P
Citation: A. Robert et al., CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO, Thrombosis and haemostasis, 80(1), 1998, pp. 99-103
PSEUDO-HOMOZYGOUS ACTIVATED PROTEIN-C RESISTANCE DUE TO COINHERITANCEOF HETEROZYGOUS FACTOR-V-LEIDEN MUTATION AND TYPE-I FACTOR-V DEFICIENCY - VARIABLE EXPRESSION WHEN ANALYZED BY DIFFERENT ACTIVATED PROTEIN-C RESISTANCE FUNCTIONAL ASSAYS
Authors: DELAHOUSSE B IOCHMANN S POUPLARD C FIMBEL B CHARBONNIER B GRUEL Y
Citation: B. Delahousse et al., PSEUDO-HOMOZYGOUS ACTIVATED PROTEIN-C RESISTANCE DUE TO COINHERITANCEOF HETEROZYGOUS FACTOR-V-LEIDEN MUTATION AND TYPE-I FACTOR-V DEFICIENCY - VARIABLE EXPRESSION WHEN ANALYZED BY DIFFERENT ACTIVATED PROTEIN-C RESISTANCE FUNCTIONAL ASSAYS, Blood coagulation & fibrinolysis, 8(8), 1997, pp. 503-509
DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED DURING LOW-MOLECULAR-WEIGHT-HEPARIN THERAPY AND HIGHER CROSS-REACTIVITY WITH ORGARAN
Authors: POUPLARD C AMIRAL J BORG JY VISSAC AM DELAHOUSSE B REVERDIAUMOALIC P GRUEL Y
Citation: C. Pouplard et al., DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED DURING LOW-MOLECULAR-WEIGHT-HEPARIN THERAPY AND HIGHER CROSS-REACTIVITY WITH ORGARAN, Thrombosis and haemostasis, 1997, pp. 1826-1826
DEVELOPMENT OF ANTIBODIES SPECIFIC TO PF4 HEPARIN COMPLEXES IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS/
Authors: POUPLARD C MAY MA DELAHOUSSE B AXELROUD S WILMOUTH L AMIRAL J MARCHAND M GRUEL Y
Citation: C. Pouplard et al., DEVELOPMENT OF ANTIBODIES SPECIFIC TO PF4 HEPARIN COMPLEXES IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS/, Thrombosis and haemostasis, 1997, pp. 1830-1830
CLINICAL AND BIOLOGICAL DATA IN 68 SUBJECTS WITH HOMOZYGOUS R506Q MUTATION - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY
Authors: AILLAUD MF JUHAN I BAUTERS A JUDE B BIRON C SCHVED JF PERNOD G POLACK B DELAHOUSSE B FIMBEL B MARQUESVERDIER A BRIDEY F TRUCHAUD F TROSSAERT M BIHOUR C VERGNES C GRIS JC DENNINGER MH DUTRILLAUX F LORENZINI JL HOUBOUYAN L LEQUERREC A FREYBURGER G BORG JY BOINOT C SULTAN Y TREZIACK MC BERRUYER M GUERIN V TOULON P MASSIGNON D DESCHAMPS A FAVIER R ROBERT A JULIA A
Citation: Mf. Aillaud et al., CLINICAL AND BIOLOGICAL DATA IN 68 SUBJECTS WITH HOMOZYGOUS R506Q MUTATION - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY, Thrombosis and haemostasis, 1997, pp. 2368-2368
DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED IN HEPARIN-INDUCED THROMBOCYTOPENIA AND CONSEQUENCES ON CROSS-REACTIVITY WITH DANAPAROID SODIUM
Authors: POUPLARD C AMIRAL J BORG JY VISSAC AM DELAHOUSSE B GRUEL Y
Citation: C. Pouplard et al., DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED IN HEPARIN-INDUCED THROMBOCYTOPENIA AND CONSEQUENCES ON CROSS-REACTIVITY WITH DANAPAROID SODIUM, British Journal of Haematology, 99(2), 1997, pp. 273-280
CLINICAL AND BIOLOGICAL DATA IN 85-R506Q HOMOZYGOTES - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY
Authors: BIRON C SCHVED JF AILLAUD MF JUHAN I BAUTERS A JUDE B PERNOD G POLACK B BRIDEY F DEPROST D BORG JY SALADIN C LECAM V DENNINGER MH TRUCHAUD F TROSSAERT M BOINOT C SULTAN Y DELAHOUSSE B FIMBEL B GRUEL Y HOUBOUYAN L BIHOUR C VERGNES C DUTRILLAUX F LORENZINI JL JULIA A DESCHAMPS A FAVIER R FREYBURGER G TREZIACK MC BERRUYER M GRIS JC TOULON P MARQUESVERDIER A LEQUERREC A GUERIN V MASSIGNON D
Citation: C. Biron et al., CLINICAL AND BIOLOGICAL DATA IN 85-R506Q HOMOZYGOTES - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY, Blood, 90(10), 1997, pp. 654-654
EVOLUTION OF BLOOD-COAGULATION ACTIVATORS AND INHIBITORS IN THE HEALTHY-HUMAN FETUS
Authors: REVERDIAUMOALIC P DELAHOUSSE B BODY G BARDOS P LEROY J GRUEL Y
Citation: P. Reverdiaumoalic et al., EVOLUTION OF BLOOD-COAGULATION ACTIVATORS AND INHIBITORS IN THE HEALTHY-HUMAN FETUS, Blood, 88(3), 1996, pp. 900-906
FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - THE PROCARE STUDY
Authors: BIRON C SCHVED HF AILLAUD MF JUHAN I BAUTERS A JUDE B PERNOD G POLACK B DELAHOUSSE B FIMBEL B MARQUESVERDIER A BRIDEY F TRUCHAUD F TROSSAERT M BIHOUR C VERGNES C GRIS JC DENNINGER MH DUTRILLAUX F LORENZINI JL HOUBOUYAN L LEQUERREC A FREYBURGER G BORG JY BOINOT C SULTAN Y TREZIACK MC BERURRIER M GUERIN V TOULON P MASSIGNON D DESCHAMPS A FAVIER R JULIA A
Citation: C. Biron et al., FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - THE PROCARE STUDY, Blood, 88(10), 1996, pp. 685-685
EVALUATION OF D-DIMER LATEX MEASUREMENT IN PATIENTS WITH CLINICALLY SUSPECTED DEEP VENOUS THROMBOSIS (DVT) OR PULMONARY-EMBOLISM (PE)
Authors: DELAHOUSSE B COLIN B PACOURET G CHARBONNIER B GRUEL Y
Citation: B. Delahousse et al., EVALUATION OF D-DIMER LATEX MEASUREMENT IN PATIENTS WITH CLINICALLY SUSPECTED DEEP VENOUS THROMBOSIS (DVT) OR PULMONARY-EMBOLISM (PE), Thrombosis and haemostasis, 73(6), 1995, pp. 1141-1141
MARKERS OF HEMOSTATIC SYSTEM ACTIVATION IN ACUTE DEEP VENOUS THROMBOSIS-EVOLUTION DURING THE FIRST DAYS OF HEPARIN TREATMENT
Authors: ALEXANDRE P AMIRAL J BIENVENU J BORG JY BRIDEY F CAHAN L COMBE S DELAHOUSSE B DREYFUS M GAUTHIER C JUHANVAGUE I LANDAUER D MUSITELLI JJ POUZOL P RAISKY F REYNAUD J SIE P SITBON O TREZIAC MC
Citation: P. Alexandre et al., MARKERS OF HEMOSTATIC SYSTEM ACTIVATION IN ACUTE DEEP VENOUS THROMBOSIS-EVOLUTION DURING THE FIRST DAYS OF HEPARIN TREATMENT, Thrombosis and haemostasis, 70(6), 1993, pp. 909-914
ACQUIRED FACTOR-V INHIBITOR WITHOUT HEMORRHAGIC MANIFESTATIONS DESPITE VERY HIGH ANTIBODY-TITERS
Authors: DELAHOUSSE B GRUEL Y REVERDIAU P BIBAS D HETROY J COUZON T LEROY J
Citation: B. Delahousse et al., ACQUIRED FACTOR-V INHIBITOR WITHOUT HEMORRHAGIC MANIFESTATIONS DESPITE VERY HIGH ANTIBODY-TITERS, Thrombosis and haemostasis, 69(6), 1993, pp. 1217-1217
Risultati: 1-13 |